Nueclear Web Banner
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
CORRESPONDENCE
Ahead of Print

Intermediate dose cytarabine in treatment myeloid sarcoma of the bilateral breast after allogeneic stem cell transplantation: A case report and literature review


1 Department of Internal Medicine, Taleghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Department of Pathology, Taleghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Correspondence Address:
Mozaffar Aznab,
Department of Internal Medicine, Taleghani Hospital, Kermanshah University of Medical Science, Shahid Beheshti BLND, Kermanshah
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Myeloid sarcoma can be occurred bofore acute myeloid leukemia, concomitantly, at relapse or after allogenic stem cell transplantation, rarely. In this investigation, we reported a 38-year-old woman with a history of AML relapsed 9 months after allo-SCT as an MS in the bilateral breast. She underwent bilateral mastectomy. The patient was a candidate for systemic chemotherapy. An intermediate dose of cytarabine with mitoxantrone was considered for the patient, and it was repeated at the specified intervals. Currently, the patient is still being followed up, and there is no sign of local or systemic recurrence.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Aznab M
    -  Khazaie M
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed489    
    PDF Downloaded40    

Recommend this journal